Evercore ISI on Vera Therapeutics (VERA): 'We are comfortable buying the stock on weakness'
Tweet Send to a Friend
Evercore ISI analyst Liisa Bayko reiterated an Outperform rating and $30.00 price target on Vera Therapeutics (NASDAQ: VERA)The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
